ICON CLINICAL (UK) LIMITED
Get an alert when ICON CLINICAL (UK) LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2027-03-29 (in 10mo)
Last made up 2026-03-15
Watchouts
Cash
£3M
-2.5% vs 2023
Net assets
£470M
+16.2% vs 2023
Employees
1,371
-13.7% vs 2023
Profit before tax
£85M
+0.9% vs 2023
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
1 PSC ceased in last 24 months
Significant control changed hands — see the Ownership section.
Net assets
2-year trend · vs Technology median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £345,796,737 | £291,734,199 | |
| Operating profit | £59,011,477 | £68,332,008 | |
| Profit before tax | £84,535,759 | £85,332,300 | |
| Net profit | £67,087,583 | £64,416,062 | |
| Cash | £2,629,805 | £2,564,282 | |
| Total assets less current liabilities | £404,488,410 | £470,150,861 | |
| Net assets | £404,488,410 | £470,150,861 | |
| Equity | £404,488,410 | £470,150,861 | |
| Average employees | 1,588 | 1,371 | |
| Wages | £96,764,875 | £85,608,333 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | 17.1% | 23.4% | |
| Net margin | 19.4% | 22.1% | |
| Return on capital employed | 14.6% | 14.5% | |
| Gearing (liabilities / total assets) | 42.2% | 37.4% | |
| Current ratio | 2.30x | 2.61x | |
| Interest cover | 19.09x | 20.24x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- KPMG
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors believe that the Company has adequate resources to continue in operational existence for at least the next 12 months and that it is appropriate to adopt the going concern basis in preparing the financial statements.”
Group structure
- ICON CLINICAL (UK) LIMITED · parent
- Pharmaceutical Research Associates Sp.z.o.o 1%
- Pharmaceutical Research Associates Singapore Pte. Ltd 1%
- Pharmaceutical Research Associates Taiwan Inc. 1%
- Pharmaceutical Research Associates Israel Ltd. 1%
- PRA Health Sciences Chile SpA 0.0264%
- IMP Logistics UK Limited 1%
Significant events
- “On 29 May 2025, the Company paid an interim dividend of £107,259,997.24 to its sole shareholder, ICON Clinical Research Holdings (U.K.) Limited.”
- “Effective from 2 June 2025, the Company changed its name from Pharm Research Associates (UK) Limited to ICON Clinical (UK) Limited.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
5 active · 18 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| FOX, Erina | Secretary | 2024-05-24 | — | — |
| HOLLYWOOD, Simon Peter | Director | 2021-12-06 | Jan 1980 | Irish |
| HORGAN, Shane | Director | 2025-09-29 | Sep 1987 | Irish |
| MACDONALD, John | Director | 2025-03-14 | Mar 1967 | British |
| VAN WYK, Quintin, Dr | Director | 2025-03-14 | Aug 1970 | British |
Show 18 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| VOLLMAR, Joachim | Secretary | 1996-09-27 | 1998-07-07 |
| MH SECRETARIES LIMITED | Corporate Secretary | 1998-07-07 | 2000-02-08 |
| MITRE SECRETARIES LIMITED | Corporate Secretary | 1999-05-24 | 2024-05-24 |
| SWIFT INCORPORATIONS LIMITED | Corporate Nominee Secretary | 1996-09-09 | 1996-09-27 |
| BROWN, Tracy | Director | 2023-06-19 | 2025-03-14 |
| DONNELLY, Patrick Kevin | Director | 1999-03-25 | 2006-12-14 |
| FOTOPOULOS, Spiro | Director | 2005-03-30 | 2007-08-03 |
| GRAY, Christopher John | Director | 2011-10-10 | 2021-12-30 |
| LEDFORD, Greg | Director | 1999-03-25 | 2001-08-07 |
| LEFTWICH, Robert James | Director | 2021-07-01 | 2023-06-19 |
| MARTIN, Earle Wilson | Director | 1996-09-27 | 2001-08-07 |
| MCELHINNEY, Emer | Director | 2025-03-14 | 2025-09-29 |
| SHANNON, Colin | Director | 2007-06-19 | 2021-07-01 |
| STANSFIELD, Susan Caroline | Director | 2008-12-23 | 2011-09-30 |
| THOMAS, David Russell | Director | 1997-11-01 | 2004-03-31 |
| VOLLMAR, Joachim | Director | 1996-09-27 | 2001-08-07 |
| WRIGHT, Nicola Clare | Director | 2004-03-04 | 2005-05-18 |
| INSTANT COMPANIES LIMITED | Corporate Nominee Director | 1996-09-09 | 1996-09-27 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Icon Clinical Research (U.K.) Limited | Corporate entity | Shares 75–100%, Voting 75–100% | 2025-05-31 | Active |
| Icon Clinical Research Holdings (U.K.) Limited | Corporate entity | Shares 75–100%, Voting 75–100% | 2022-10-26 | Ceased 2025-05-31 |
| Icon Plc | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2021-07-01 | Ceased 2022-10-25 |
| Pra Health Sciences, Inc. | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Ceased 2021-07-01 |
Filing timeline
Last 20 of 159 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-04-07 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2026-01-30 | AUD | auditors | Auditors resignation company | |
| 2026-01-03 | AA | accounts | Accounts with accounts type full | |
| 2025-10-01 | AP01 | officers | Appoint person director company with name date | |
| 2025-10-01 | TM01 | officers | Termination director company with name termination date | |
| 2025-07-07 | SH01 | capital | Capital allotment shares | |
| 2025-06-06 | MA | incorporation | Memorandum articles | |
| 2025-06-04 | RESOLUTIONS | resolution | Resolution | |
| 2025-06-03 | AD01 | address | Change registered office address company with date old address new address | |
| 2025-06-03 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2025-06-02 | PSC02 | persons-with-significant-control | Notification of a person with significant control | |
| 2025-06-02 | CERTNM | change-of-name | Certificate change of name company | |
| 2025-03-27 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-03-26 | AP01 | officers | Appoint person director company with name date | |
| 2025-03-26 | AP01 | officers | Appoint person director company with name date | |
| 2025-03-26 | AP01 | officers | Appoint person director company with name date | |
| 2025-03-26 | TM01 | officers | Termination director company with name termination date | |
| 2025-03-06 | AA | accounts | Accounts with accounts type full | |
| 2024-07-15 | AP03 | officers | Appoint person secretary company with name date | |
| 2024-05-24 | TM02 | officers | Termination secretary company with name termination date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 12
- Capital events
- 1
- Officers appointed
- 1
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
-15.6%
£345,796,737 £291,734,199
-
Cash
-2.5%
£2,629,805 £2,564,282
-
Net assets
+16.2%
£404,488,410 £470,150,861
-
Employees
-13.7%
1,588 1,371
-
Operating profit
+15.8%
£59,011,477 £68,332,008
-
Profit before tax
+0.9%
£84,535,759 £85,332,300
-
Wages
-11.5%
£96,764,875 £85,608,333
Each % is (latest − prior) ÷ |prior| for the line item as filed. Periods don't have to be exactly 12 months apart — a long or short period (typical around incorporation or year-end changes) will distort the comparison. Lines a company doesn't report are omitted. About these numbers